Stockholm - Delayed Quote SEK

PExA AB (PEXA-B.ST)

0.3080
+0.0180
+(6.21%)
At close: 3:31:39 PM GMT+2

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
NameTitlePayExercisedYear Born
Mr. Tomas Gustafsson MD & CEO -- -- 1971
Ms. Anna-Carin Olin Founder, Research Director & Director -- -- 1960
Ms. Asa Wheelock Ph.D. Scientific Advisor & Director -- -- 1970
Mr. Jörgen Östling C.S.O -- -- 1962

PExA AB

Arvid Wallgrens Backe 20
Gothenburg, 413 46
Sweden
46 7 05 86 43 80 https://pexa.se
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
3

Description

PExA AB (publ) develops and commercializes diagnostic products in various respiratory diseases. It offers its products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary diseases. The company's research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. It offers PExA 2.0, an instrument for the non-invasive collection of particles in exhaled air. The company also provides accessories, which include substrate surfaces and nozzles, as well as parts and service kits. It provides its products for lung research centers within the health services, academia, and pharmaceutical companies. The company was founded in 2004 and is based in Gothenburg, Sweden.

Corporate Governance

PExA AB’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events